Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
03/2011
03/30/2011CN101993410A Organic light-emitting device
03/30/2011CN101993409A Heterocyclic compound, organic light-emitting device containing polycyclic heteroaryl compounds
03/30/2011CN101993408A Method for preparing 2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl) glutaric acid-5-benzyl ester
03/30/2011CN101993407A Indoline compound for preparing silodosin and preparation method thereof
03/30/2011CN101993406A Indoline compound with optical activity and preparation method thereof
03/30/2011CN101993405A Indoline derivative as well as preparation method and application thereof
03/30/2011CN101993395A Compound and photoresist composition containing the same
03/30/2011CN101565396B Technique for refining L-tryptophan
03/30/2011CN101279969B Organic electroluminescent material and application thereof
03/30/2011CN101274910B Preparation of tert-butyl (3R, 5R)-3,5-dihydroxy-7-N-phthaloylimino heptanonate
03/29/2011US7915430 Catalytic method for producing phenolphthalein compounds
03/29/2011US7915428 Photorefractive dendron compound, photorefractive dendrimer compound, method of preparing the same, photorefractive device using the same, and method of manufacturing the device
03/29/2011US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases
03/29/2011US7915282 Preparation by intramolecular cyclization
03/29/2011US7915260 Urotensin II receptor antagonists
03/29/2011US7915249 serotonin 5-HT2A, 5-HT2C and dopamin D2 receptors antagonist, and norepinephrine reuptake inhibitor; antidepressant, anxiolytic agent; psychosis, schizophrenia, bipolar and sexual disorders, obesity
03/29/2011US7914706 Charge transport compositions and electronic devices made with such compositions
03/29/2011CA2610354C Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
03/29/2011CA2506564C An improved process for the preparation of gabalactam
03/29/2011CA2489276C Tricyclic steroid hormone nuclear receptor modulators
03/29/2011CA2452845C Dye-sulfenates for dual phototherapy
03/29/2011CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
03/29/2011CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof
03/29/2011CA2383779C N-(indolecarbonyl)piperazine derivatives
03/24/2011WO2011035332A1 Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators
03/24/2011WO2011034078A1 Glycine compound
03/24/2011WO2011033207A1 Cosmetic composition including leucodopachrome derivative
03/24/2011WO2011033099A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
03/24/2011WO2011032320A1 Novel alkene oxindole derivatives
03/24/2011WO2010131922A3 Amide compound, preparation method thereof and pharmaceutical composition comprising same
03/24/2011WO2010110545A3 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
03/24/2011US20110071304 Aromatic amide derivative
03/24/2011US20110071202 Anti-hepatitis c virus agents and anti-hiv agents
03/24/2011US20110071195 Novel alkene oxindole derivatives
03/24/2011US20110071175 Indoles and Their Therapeutic Use
03/24/2011US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof
03/24/2011US20110070161 Active enantiomer
03/24/2011US20110068683 Anthracene derivatives, luminescent materials and organic electroluminescent devices
03/24/2011CA2772689A1 Glycine compound
03/24/2011CA2772674A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
03/23/2011EP2298741A1 1H-benzo[g]indole compounds and organic luminescence device using the same
03/23/2011EP2298740A1 1-H-benzo[g]indole compounds and organic lightemitting device including the same
03/23/2011EP2298739A1 Organic light emitting device containing polycyclic heteroaryl compounds
03/23/2011EP2298738A1 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
03/23/2011EP2298737A1 Indole compounds and organic light-emitting device including the same
03/23/2011EP2298732A1 7,9-Substituted tetracycline compounds
03/23/2011EP2298311A1 w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
03/23/2011EP2297100A1 Tetrahydrocyclopentaýb¨indole androgen receptor modulators
03/23/2011EP2297099A1 3-cyanoalkyl- and 3-hydroxyalkylindoles and use thereof
03/23/2011EP2297091A1 Insecticidal compounds
03/23/2011EP2297088A2 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode
03/23/2011EP2297075A1 Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization
03/23/2011EP2229358B1 Indoles and their therapeutic use
03/23/2011EP2081893B1 Substituted indoles
03/23/2011CN101990533A Novel salt of tegaserod
03/23/2011CN101987832A Preparation method of 2-trifluoromethyl indole derivatives
03/23/2011CN101987822A Organic electroluminescent material and application thereof
03/23/2011CN101048376B Indoline compound and process for producing the same
03/22/2011US7910753 Cyanine dyes and their applications as luminescence quenching compounds
03/22/2011US7910745 Organic compound and method for producing radioactive halogen-labeled organic compound using the same
03/22/2011US7910591 e.g. 3-[4-(4-Pyridine-2-yl-piperazine-1-yl)-butyl]-1,3-dihydro-2H-indol-2-one; serotonin 5-HT7 and alpha 1 receptors modulator; antxiolytic agent, antidepressant; neurodegenerative diseases; schizophrenia, Alzheimer's disease, stroke, dementias; side effect reduction
03/22/2011US7910584 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
03/22/2011US7908735 Method and installation means for installing an electrical machine
03/22/2011CA2498091C Sulfonylamino-acetic acid derivatives
03/22/2011CA2471628C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application
03/22/2011CA2471538C Pyrrolopyrimidines
03/17/2011WO2011031111A2 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient
03/17/2011WO2011030645A1 Photopolymerizable composition, color filter, method for producing same, solid-state image pickup element, liquid crystal display device, lithographic printing original plate, and novel compound
03/17/2011WO2011030356A2 Process for the preparation of indoline derivatives and their intermediates thereof
03/17/2011WO2011030330A2 Process for the purification of ropinirole hydrochloride
03/17/2011WO2011030068A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
03/17/2011WO2011006803A8 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition
03/17/2011WO2010028776A8 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/17/2011US20110065930 Process for the synthesis of (2s,3ar,7as)-octahydro-1h-indole carboxylic acid as an intermediate for trandolapril
03/17/2011US20110065929 Homogeneous asymmetric hydrogenation catalyst
03/17/2011US20110065919 5-Substituted Indol-3-Carboxylic Acid Derivatives Exhibiting Antiviral Activity a Method for the Production and Use Thereof
03/17/2011US20110065768 Non-steroidal androgens compounds
03/17/2011US20110065685 Novel indoles are cannabinoid receptor ligands
03/17/2011US20110065622 Novel nitrile and amidoxime compounds and methods of preparation for semiconductor processing
03/17/2011CA2772997A1 Process for the preparation of indoline derivatives and their intermediates thereof
03/17/2011CA2772697A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
03/17/2011CA2770343A1 Synthetic mycotoxin adsorbents and methods of making and utilizing the same
03/16/2011EP2295503A1 Dibenzorhodamine dyes useful as fluorescent labelling agents
03/16/2011EP2295409A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists
03/16/2011EP2295408A1 Matrix metalloproteinase inhibitors
03/16/2011EP2295401A2 Deuterated hepatitis C protease inhibitors
03/16/2011EP2295055A2 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof
03/16/2011EP2294051A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
03/16/2011EP1833790B1 Process for the preparation of alkyl 5-(dicarboximido)levulinate and alkyl 4-oxo-pentenoate
03/16/2011EP1809598B1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
03/16/2011EP1699761B1 Cb1 modulator compounds
03/16/2011CN201762270U Production device of 5-hydroxyltryptophan
03/16/2011CN201762269U Separation and purification device for 5-hydroxytryptophan
03/15/2011US7906677 Process for phenylacetic acid derivatives
03/15/2011US7906653 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/15/2011US7906650 Caspase inhibitors and uses thereof
03/15/2011US7906649 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
03/15/2011US7906547 Azabicylic compounds, a process for their preparation and pharmaceutical compositions containing them
03/15/2011US7906546 Tetrahydrocarbazoles and derivatives
03/15/2011US7906545 Prodrugs of CC-1065 analogs
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 458